Financial Gravity Asset Management, Inc. Twist Bioscience Corp Transaction History

Financial Gravity Asset Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$32.28 - $41.5 $96 - $124	3 Added 150.0%	5 $206,000
Q4 2023 Jun 26, 2024	SELL	$15.08 - $38.61 $45 - $115	-3 Reduced 60.0%	2 $75,000
Q3 2023 Nov 15, 2023	SELL	$18.62 - $26.57 $335 - $478	-18 Reduced 90.0%	2 $0
Q2 2023 Aug 08, 2023	BUY	$11.49 - $20.46 $57 - $102	5 Added 33.33%	20 $127,000
Q1 2023 May 12, 2023	SELL	$14.6 - $30.9 $131 - $278	-9 Reduced 37.5%	15 $5,000
Q4 2022 Feb 15, 2023	SELL	$21.92 - $39.37 $1,775 - $3,188	-81 Reduced 77.14%	24 $39,000
Q2 2022 Aug 05, 2022	SELL	$26.2 - $54.0 $1,100 - $2,268	-42 Reduced 28.57%	105 $13,000
Q1 2022 May 13, 2022	SELL	$38.58 - $83.27 $3,240 - $6,994	-84 Reduced 36.36%	147 $17,000
Q4 2021 Feb 11, 2022	BUY	$75.47 - $135.88 $17,433 - $31,388	231 New	231 $26,000
Q3 2021 Nov 12, 2021	BUY	$95.64 - $131.48 $0 - $0	0 New	0 $107,000

256

66.8M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.38B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.